List of Contents

Stem Cell Banking Market Size, Share, and Trends 2024 to 2033

Stem Cell Banking Market (By Service Type: Collection & Transportation, Processing, Analysis, Storage; By Utilization: Used, Unused; By Cell Type: Umbilical Cord Stem Cell, Adult Stem Cell, Embryonic Stem Cell; By Bank Type: Public, Private) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

  • Last Updated : June 2024
  • Report Code : 4558
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Stem Cell Banking Market 

5.1. COVID-19 Landscape: Stem Cell Banking Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Stem Cell Banking Market, By Service Type

8.1. Stem Cell Banking Market, by Service Type, 2024-2033

8.1.1. Collection & Transportation

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Processing

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Analysis

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. Storage

8.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Stem Cell Banking Market, By Utilization

9.1. Stem Cell Banking Market, by Utilization, 2024-2033

9.1.1. Used

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Unused

9.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Stem Cell Banking Market, By Cell Type 

10.1. Stem Cell Banking Market, by Cell Type, 2024-2033

10.1.1. Umbilical Cord Stem Cell

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Adult Stem Cell

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.3. Embryonic Stem Cell

10.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Stem Cell Banking Market, By Bank Type 

11.1. Stem Cell Banking Market, by Bank Type, 2024-2033

11.1.1. Public

11.1.1.1. Market Revenue and Forecast (2021-2033)

11.1.2. Private

11.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 12. Global Stem Cell Banking Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Service Type (2021-2033)

12.1.2. Market Revenue and Forecast, by Utilization (2021-2033)

12.1.3. Market Revenue and Forecast, by Cell Type (2021-2033)

12.1.4. Market Revenue and Forecast, by Bank Type (2021-2033)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Service Type (2021-2033)

12.1.5.2. Market Revenue and Forecast, by Utilization (2021-2033)

12.1.5.3. Market Revenue and Forecast, by Cell Type (2021-2033)

12.1.5.4. Market Revenue and Forecast, by Bank Type (2021-2033)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Service Type (2021-2033)

12.1.6.2. Market Revenue and Forecast, by Utilization (2021-2033)

12.1.6.3. Market Revenue and Forecast, by Cell Type (2021-2033)

12.1.6.4. Market Revenue and Forecast, by Bank Type (2021-2033)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Service Type (2021-2033)

12.2.2. Market Revenue and Forecast, by Utilization (2021-2033)

12.2.3. Market Revenue and Forecast, by Cell Type (2021-2033)

12.2.4. Market Revenue and Forecast, by Bank Type (2021-2033)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Service Type (2021-2033)

12.2.5.2. Market Revenue and Forecast, by Utilization (2021-2033)

12.2.5.3. Market Revenue and Forecast, by Cell Type (2021-2033)

12.2.5.4. Market Revenue and Forecast, by Bank Type (2021-2033)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Service Type (2021-2033)

12.2.6.2. Market Revenue and Forecast, by Utilization (2021-2033)

12.2.6.3. Market Revenue and Forecast, by Cell Type (2021-2033)

12.2.6.4. Market Revenue and Forecast, by Bank Type (2021-2033)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Service Type (2021-2033)

12.2.7.2. Market Revenue and Forecast, by Utilization (2021-2033)

12.2.7.3. Market Revenue and Forecast, by Cell Type (2021-2033)

12.2.7.4. Market Revenue and Forecast, by Bank Type (2021-2033)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Service Type (2021-2033)

12.2.8.2. Market Revenue and Forecast, by Utilization (2021-2033)

12.2.8.3. Market Revenue and Forecast, by Cell Type (2021-2033)

12.2.8.4. Market Revenue and Forecast, by Bank Type (2021-2033)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Service Type (2021-2033)

12.3.2. Market Revenue and Forecast, by Utilization (2021-2033)

12.3.3. Market Revenue and Forecast, by Cell Type (2021-2033)

12.3.4. Market Revenue and Forecast, by Bank Type (2021-2033)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Service Type (2021-2033)

12.3.5.2. Market Revenue and Forecast, by Utilization (2021-2033)

12.3.5.3. Market Revenue and Forecast, by Cell Type (2021-2033)

12.3.5.4. Market Revenue and Forecast, by Bank Type (2021-2033)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Service Type (2021-2033)

12.3.6.2. Market Revenue and Forecast, by Utilization (2021-2033)

12.3.6.3. Market Revenue and Forecast, by Cell Type (2021-2033)

12.3.6.4. Market Revenue and Forecast, by Bank Type (2021-2033)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Service Type (2021-2033)

12.3.7.2. Market Revenue and Forecast, by Utilization (2021-2033)

12.3.7.3. Market Revenue and Forecast, by Cell Type (2021-2033)

12.3.7.4. Market Revenue and Forecast, by Bank Type (2021-2033)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Service Type (2021-2033)

12.3.8.2. Market Revenue and Forecast, by Utilization (2021-2033)

12.3.8.3. Market Revenue and Forecast, by Cell Type (2021-2033)

12.3.8.4. Market Revenue and Forecast, by Bank Type (2021-2033)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Service Type (2021-2033)

12.4.2. Market Revenue and Forecast, by Utilization (2021-2033)

12.4.3. Market Revenue and Forecast, by Cell Type (2021-2033)

12.4.4. Market Revenue and Forecast, by Bank Type (2021-2033)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Service Type (2021-2033)

12.4.5.2. Market Revenue and Forecast, by Utilization (2021-2033)

12.4.5.3. Market Revenue and Forecast, by Cell Type (2021-2033)

12.4.5.4. Market Revenue and Forecast, by Bank Type (2021-2033)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Service Type (2021-2033)

12.4.6.2. Market Revenue and Forecast, by Utilization (2021-2033)

12.4.6.3. Market Revenue and Forecast, by Cell Type (2021-2033)

12.4.6.4. Market Revenue and Forecast, by Bank Type (2021-2033)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Service Type (2021-2033)

12.4.7.2. Market Revenue and Forecast, by Utilization (2021-2033)

12.4.7.3. Market Revenue and Forecast, by Cell Type (2021-2033)

12.4.7.4. Market Revenue and Forecast, by Bank Type (2021-2033)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Service Type (2021-2033)

12.4.8.2. Market Revenue and Forecast, by Utilization (2021-2033)

12.4.8.3. Market Revenue and Forecast, by Cell Type (2021-2033)

12.4.8.4. Market Revenue and Forecast, by Bank Type (2021-2033)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Service Type (2021-2033)

12.5.2. Market Revenue and Forecast, by Utilization (2021-2033)

12.5.3. Market Revenue and Forecast, by Cell Type (2021-2033)

12.5.4. Market Revenue and Forecast, by Bank Type (2021-2033)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Service Type (2021-2033)

12.5.5.2. Market Revenue and Forecast, by Utilization (2021-2033)

12.5.5.3. Market Revenue and Forecast, by Cell Type (2021-2033)

12.5.5.4. Market Revenue and Forecast, by Bank Type (2021-2033)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Service Type (2021-2033)

12.5.6.2. Market Revenue and Forecast, by Utilization (2021-2033)

12.5.6.3. Market Revenue and Forecast, by Cell Type (2021-2033)

12.5.6.4. Market Revenue and Forecast, by Bank Type (2021-2033)

Chapter 13. Company Profiles

13.1. Cordlife

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Cryo-Save AG

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Stemcyte

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Smart Cells International Ltd.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Cordvida

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. CBR Systems Inc.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Lifecell

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Cryoviva India

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Cryo-Cell

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Viacord

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client